Page last updated: 2024-08-17

carbostyril and Pharyngitis

carbostyril has been researched along with Pharyngitis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Goda, K; Hashimoto, H; Hatakeyama, S; Kitsuregawa, M; Mitsutake, N; Nagai, R; Saito, M; Sato, J1
Escapa-Garrachón, J; Hidalgo, SF; Martín-Serradilla, JI; Prieto de Paula, JM1
Erdogan, S; Finke, EJ; Gedikoglu, S; Grunow, R; Meric, M; Sayan, M; Willke, A1

Other Studies

3 other study(ies) available for carbostyril and Pharyngitis

ArticleYear
Indications and classes of outpatient antibiotic prescriptions in Japan: A descriptive study using the national database of electronic health insurance claims, 2012-2015.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 91

    Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antimicrobial Stewardship; Cephalosporins; Child; Child, Preschool; Communicable Diseases; Databases, Factual; Drug Prescriptions; Female; Humans; Infant; Infant, Newborn; Insurance, Health; Japan; Macrolides; Male; Middle Aged; Outpatients; Pharyngitis; Quinolones; Respiratory Tract Infections; Sinusitis; Young Adult

2020
Quinolones and oropharyngeal tularemia.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:12

    Topics: Antibodies, Bacterial; Francisella tularensis; Humans; Pharyngitis; Quinolones; Treatment Outcome; Tularemia

2008
Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia.
    APMIS : acta pathologica, microbiologica, et immunologica Scandinavica, 2008, Volume: 116, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Blood Sedimentation; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Lymphatic Diseases; Male; Middle Aged; Pharyngitis; Quinolones; Risk Factors; Time Factors; Treatment Outcome; Tularemia; Turkey

2008